regeneron pharmaceuticals semaglutide & Hansoh's GLP-1 Deal Semaglutide Combinations Show Promise in – Semaglutide GLP-1 Receptor Agonist Research – Semaglutide Weightloss Injections Lafayette, LA

News provided by University of Colorado Anschutz Jul 29, 2026, 00:00 ET A study from the University of Colorado Anschutz found that the popular diabetes and weight loss drug reduced heavy drinking and alcohol-related harm in adults with Alcohol Use Disorder AURORA, Colo., July 29, 2026 /PRNewswire/ -- A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy drinking in adults with Alcohol Use Disorder (AUD)

La vitamina C no es esencial para la sntesis de carnitina

After exploring the mechanism of action in diabetic fatty rats and obese mice, researchers rapidly moved on to show the same effect in humans

The people who could benefit most from these medications are often those least able to afford them, perpetuating a cycle in which geography, income, and health outcomes remain tightly intertwined